Showing results (1351-1360 of 1,708) with videos related to

Sort By:
Pageof 171
European Heart Journal Open|August 29, 2023
Cardiovascular outcomes in patients with coronary artery disease and elevated lipoprotein(a): implications for the OCEAN(a)-outcomes trial populationArthur Shiyovich, Adam N Berman, Stephanie A Besser, et al.
Frontiers in Cardiovascular Medicine|August 21, 2023
Quantitative imaging biomarkers of coronary plaque morphology: insights from EVAPORATEAndrew J Buckler, Gheorghe Doros, April Kinninger, et al.
Journal of Cardiac Failure|March 2, 2026
Sotagliflozin, suPAR, and Cardiovascular Outcomes in Patients with Diabetes and Heart Failure: A SOLOIST-WHF Ancillary StudyAnis Ismail, Grace Erne, Alexi Vasbinder, et al.
Journal of the American Heart Association|February 9, 2021
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial InfarctionGiulia Magnani, Diego Ardissino, KyungAh Im, et al.
Cell Metabolism|September 4, 2019
SGLT2 Inhibition with Empagliflozin Increases Circulating Provascular Progenitor Cells in People with Type 2 Diabetes MellitusDavid A Hess, Daniella C Terenzi, Justin Z Trac, et al.
European Heart Journal|September 22, 2018
Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trialsDavid D Berg, Stephen D Wiviott, Eugene Braunwald, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 30, 2021
Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trialThomas Vanassche, Peter Verhamme, Sonia S Anand, et al.
European Heart Journal|October 13, 2020
Women who experience a myocardial infarction at a young age have worse outcomes compared with men: the Mass General Brigham YOUNG-MI registryErsilia M DeFilippis, Bradley L Collins, Avinainder Singh, et al.
Pageof 171